Skip to main content

RDY 310 Pill - pink & yellow capsule/oblong, 18mm

Pill with imprint RDY 310 is Pink & Yellow, Capsule/Oblong and has been identified as Nizatidine 150 mg. It is supplied by Dr. Reddy’s Laboratories Inc.

Nizatidine is used in the treatment of Erosive Esophagitis; GERD; Duodenal Ulcer; Indigestion; Duodenal Ulcer Prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 310

Nizatidine 150 mg RDY 310 Front
Nizatidine 150 mg RDY 310 Back
Nizatidine 150 mg RDY 310

Nizatidine

Imprint
RDY 310
Strength
150 mg
Color
Pink & Yellow
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC)
55111-0310
Inactive Ingredients
croscarmellose sodium, povidone, corn starch, dimethicone, magnesium silicate, D&C Yellow No. 10, titanium dioxide, gelatin, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, shellac, ferrosoferric oxide, butyl alcohol, propylene glycol, FD&C Blue No. 2, alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.